Azilect

What is it?

Composition

Azilect contains rasagiline as its active ingredient. Rasagiline belongs to the monoamine oxidase type B inhibitor (MAO-B inhibitor) class and is supplied as tablets for adults with Parkinson’s disease. Exact tablet composition and inactive ingredients are stated on the pack.

How to use?

Take Azilect exactly at the prescribed daily dose and at a consistent time. The tablets may be taken with or without food. Swallow the tablet with water rather than crushing it into food or mixing it with drinks.

Common practical errors include taking an extra tablet after a difficult morning, stopping suddenly because symptoms feel improved, or changing levodopa at the same time as Azilect without a clear plan. These changes make it difficult to identify the source of new nausea, dizziness, involuntary movements, or sleepiness.

• Take the prescribed tablet once each day at a time that is easy to remember.
• Keep the same daily timing where possible.
• If a dose is missed, take the next scheduled dose at the usual time.
• Do not double the next dose.
• Do not take an extra tablet to compensate for tremor or stiffness.
• Record new movement changes for a few days, including when they occur in relation to levodopa.

The FDA prescribing information warns that rasagiline can interact with several medicines that affect serotonin, norepinephrine, dopamine, or opioid pathways. A clear and current medicine list is essential before treatment starts and whenever another prescriber suggests a new medicine. ^[2]

How does it work?

Monoamine oxidase is an enzyme that breaks down several chemical messengers. Rasagiline selectively inhibits the MAO-B form of this enzyme at recommended therapeutic use, reducing dopamine breakdown in the brain. More dopamine remains available for nerve signalling, which can improve movement symptoms in Parkinson’s disease. ^[1]

This is different from levodopa, which is converted into dopamine, and from dopamine agonists, which stimulate dopamine receptors directly. Rasagiline works by reducing dopamine loss rather than supplying or imitating dopamine itself.

Indications

Parkinson’s disease symptom control

Azilect may be prescribed:

• as single-drug treatment in early Parkinson’s disease;
• together with levodopa when symptoms return before the next levodopa dose;
• for people experiencing wearing-off periods, when mobility becomes less predictable;
• when a clinician wants to extend dopamine activity without immediately changing levodopa treatment.

The benefit can be modest but meaningful. Some people notice easier movement initiation or fewer low-mobility periods, while others mainly value more stable daily symptom control. It does not stop Parkinson’s disease from progressing, and it does not treat every non-movement symptom, such as constipation, sleep disturbance, or cognitive changes.

Comparison

Azilect is one part of Parkinson’s disease management. Choice depends on age, symptom pattern, work and driving demands, sleepiness risk, cognitive status, dyskinesia, and whether wearing-off periods have started.

Levodopa usually produces a stronger motor response than rasagiline, especially when slowness and rigidity interfere with walking, dressing, or work. Rasagiline may offer a simpler add-on option for some people, with less risk of impulse-control problems than dopamine agonists. It still carries relevant interaction risks and can contribute to dyskinesia when combined with levodopa.

The American Academy of Neurology’s 2021 guidance places levodopa at the centre of treatment for many people with early Parkinson’s disease, while recognising that individual adverse-effect risks and treatment goals shape medicine selection. ^[3]

Contraindications

• another MAO inhibitor, including selegiline;
• pethidine, also called meperidine;
• tramadol, methadone, or propoxyphene;
• dextromethorphan-containing cough suppressants;
• St John’s wort;
• cyclobenzaprine;
• linezolid, an antibiotic with MAO-inhibiting activity;
• antidepressants that increase serotonin or norepinephrine, unless a prescriber has made a specific plan.

A washout period is needed when changing between rasagiline and several interacting medicines. Fluoxetine requires special care because its long-lasting metabolite can remain in the body for weeks. The interaction concern is serotonin syndrome, a potentially serious excess of serotonin activity marked by fever, agitation, sweating, diarrhoea, muscle rigidity, and a racing heartbeat.

Liver function matters because rasagiline is processed in the liver. It should not be used in severe liver impairment. Pregnancy and breastfeeding need individual clinical assessment because Parkinson’s treatment decisions must balance maternal function with limited pregnancy safety data.

Not recommended for

Azilect is not for you if you have a known allergy to rasagiline or any tablet ingredient, or if you use another MAO inhibitor at the same time. This includes medicines used for depression, certain older psychiatric treatments, and some medicines used in movement disorders.

Side effects

Azilect is often tolerated well, though it can cause adverse effects. Headache, flu-like symptoms, joint pain, indigestion, nausea, dry mouth, and dizziness have been reported. When used with levodopa, involuntary movements may occur more often because dopamine activity increases.

Postural hypotension can occur. This means blood pressure drops after standing, causing light-headedness, blurred vision, weakness, or fainting. Rise slowly from bed or a chair, especially during the first weeks of treatment or after a medicine change.

Some reactions require faster medical attention:

• severe headache with chest pain, neck stiffness, confusion, sweating, or marked blood-pressure rise;
• fever, agitation, muscle stiffness, diarrhoea, rapid heartbeat, or tremor after combining serotonergic medicines;
• hallucinations, new confusion, or unusual suspiciousness;
• repeated fainting or a fall linked to dizziness;
• new compulsive gambling, shopping, eating, or sexual behaviour when Azilect is part of a broader dopaminergic regimen;
• excessive daytime sleepiness or unexpectedly falling asleep during routine activities.

The EMA product information describes headache and dyskinesia among recognised adverse reactions, with the pattern depending on whether rasagiline is used alone or alongside levodopa. ^[4]

Alcohol can worsen dizziness and poor coordination. It may also make it harder to judge whether fatigue, unsteadiness, or sleepiness is medicine-related.

Common mistakes

Parkinson’s symptoms naturally vary from hour to hour. This makes self-adjustment tempting, especially when tremor or stiffness appears before an important appointment. Taking extra tablets without direction can increase adverse effects without reliably improving movement.

Frequent mistakes include:

• treating Azilect as an as-needed tablet;
• doubling a missed dose;
• starting a cough mixture without checking its active ingredients;
• assuming dizziness is only part of ageing rather than a possible blood-pressure effect;
• overlooking new involuntary movements after Azilect is added to levodopa;
• stopping treatment abruptly after a brief period of improvement;
• keeping medication changes out of the neurologist’s review because the change seemed minor.

A useful record includes waking time, tablet timing, levodopa timing where relevant, off periods, falls, involuntary movements, and sleep episodes. A few concise notes can reveal patterns that memory misses during an appointment.

Doctor opinions

In neurological practice, doctors usually set realistic expectations for Azilect. It may improve day-to-day motor steadiness, but it rarely produces an immediate, dramatic change. The useful question is whether walking, turning, getting dressed, handwriting, or end-of-dose mobility becomes easier over several weeks.

Doctors also watch for changes that patients may not connect to Parkinson’s treatment. A spouse may notice daytime dozing, more vivid dreams, increased irritability, or new repetitive behaviours before the person taking the medicine mentions them. Clear reporting helps distinguish Parkinson’s progression from a medicine effect.

Azilect tends to fit best when it is part of a structured plan. Movement diaries, blood-pressure observations after standing, and a complete interaction review give more useful information than judging the medicine by a single good or bad day.

Frequently asked questions

Can Azilect be used on its own?

Azilect may be used alone in early Parkinson’s disease when symptoms are mild or when a clinician considers MAO-B inhibition appropriate. It can also be combined with levodopa later in the condition when wearing-off becomes troublesome. FDA prescribing information from 2017 describes both uses for rasagiline. The expected benefit is symptom improvement, not reversal of Parkinson’s disease. Follow-up with a neurologist helps assess the response.

How soon can movement symptoms improve?

Some people notice a gradual change over the first several weeks, while others need a longer observation period to judge benefit. The EMA product information updated in 2024 describes rasagiline as a symptomatic treatment, meaning it aims to improve motor symptoms rather than restore lost dopamine-producing cells. Daily timing and stable use make response easier to assess. A movement diary can show whether off periods become shorter or less frequent.

Can Azilect be taken with levodopa?

Yes, rasagiline is often used alongside levodopa when levodopa’s benefit does not last evenly through the day. The combination can improve motor control, though it may also increase dyskinesia or dizziness in some people. NICE guidance updated in 2022 supports treatment choices that reflect motor benefit, adverse effects, and personal priorities. A clinician may adjust other Parkinson’s medicines if involuntary movements increase.

Which cough medicines are a concern?

Dextromethorphan is a cough suppressant that should be avoided with rasagiline because of a potentially serious interaction. Combination cold products can also include decongestants that may raise blood pressure or complicate treatment. The WHO’s 2023 medicines-safety materials stress the value of checking all active ingredients in multi-symptom products. A single cold product may contain several interacting substances.

Can Azilect cause sleepiness?

Sleepiness and dizziness can occur, especially when rasagiline is used with other Parkinson’s medicines. Unexpected sleep episodes are less common but matter because they can affect driving, cooking, and other activities needing alertness. The American Academy of Neurology’s 2021 Parkinson’s guidance highlights adverse-effect monitoring as part of medicine selection. New daytime drowsiness should be reported rather than managed by changing the dose independently.

Is there a food restriction with Azilect?

At usual therapeutic use, rasagiline is selective for MAO-B and does not require the broad tyramine-restricted diet associated with older non-selective MAO inhibitors. Very large amounts of tyramine-rich foods may still be relevant if blood-pressure symptoms occur. The EMA’s 2024 product information advises attention to symptoms of hypertension rather than routine strict dietary restriction. Severe headache, palpitations, or chest discomfort after food require urgent assessment.

Do you offer anonymous delivery?

Front view

Side view

Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.